✦ LIBER ✦

The Brain Entry of HIV-1 Protease Inhibitors Is Facilitated When Used in Combination

✍ Scribed by Marzolini, Catia; Mueller, Rita; Li-Blatter, Xiaochun; Battegay, Manuel; Seelig, Anna

Book ID: 126776717
Publisher: American Chemical Society
Year: 2013
Tongue: English
Weight: 884 KB
Volume: 10
Category: Article
ISSN: 1543-8384
DOI: 10.1021/mp300712a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Entry inhibitors and their use in the tr

Entry inhibitors and their use in the treatment of HIV-1 infection

✍ Haqqani, Aiman A.; Tilton, John C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 685 KB

HPLC quantification of the HIV-1 proteas

HPLC quantification of the HIV-1 protease inhibitor saquinavir in brain and testis of mice

✍ Koteshwara Mudigonda; Raju Jukanti; Shashank S. Apte; Devender R. Ajjala; Wishu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

Quantitative Assessment of HIV-1 Proteas

Quantitative Assessment of HIV-1 Protease Inhibitor Interactions with Drug Efflux Transporters in the Blood–Brain Barrier

✍ Corbin J. Bachmeier; Timothy J. Spitzenberger; William F. Elmquist; Donald W. Mi 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 604 KB

In vitro anti-HIV-1 activity of HIV prot

In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI

✍ Sudhichai Chokekijchai; Takuma Shirasaka; John N. Weinstein; Hiroaki Mitsuya 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 828 KB

A shape- and chemistry-based docking met

A shape- and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors

✍ Renee L. DesJarlais; J. Scott Dixon 📂 Article 📅 1994 🏛 Springer Netherlands 🌐 English ⚖ 787 KB

The program DOCK [1,2] has been used successfully to identify molecules which will bind to a specified receptor [3]. The original method ranks molecules based on their shape complementarity to the receptor site and relies on the chemist to bring the appropriate electrostatic or hydrogen bond propert

Metabolism and Disposition of the HIV-1

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

✍ Gondi N. Kumar; Venkata K. Jayanti; Marianne K. Johnson; John Uchic; Samuel Thom 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 121 KB